BATRA vs BATRK

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full solvency assessment. Despite strong year-over-year earnings growth and solid operating margins, the company is unprofitable on net (negative profit margin and ROE), carries a high debt/equity ratio of 1.52, and shows poor liquidity with current and quick ratios below 1.0. Valuation metrics are stretched, with a negative forward P/E and a Price/Book of 4.80, while insider activity is decisively bearish, with recent selling by major shareholders. The stock has underperformed recently, down 13.4% over six months, and lacks analyst coverage, increasing uncertainty.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score due to insufficient data raises concerns about distress risk. Despite strong year-over-year earnings growth and a bullish analyst target price of $58.40, the company exhibits negative profitability metrics including a negative profit margin (-0.14%) and ROE (-0.17%), coupled with a bearish technical trend and significant insider selling. Valuation multiples are elevated relative to peers, while liquidity ratios suggest near-term financial strain. The stock trades well above historical performance and peer fundamentals, presenting substantial downside risk despite growth optimism.